BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory software solution providing data management and workflow management functionality across locations where clinical diagnostic activities take place. Catalog Number: 444150
This recall is currently active, issued October 8, 2024. It was issued by Becton Dickinson & Co..
- Company
- Becton Dickinson & Co.
- Recall Initiated
- September 12, 2024
- Posted
- October 8, 2024
- Recall Number
- Z-0026-2025
- Quantity
- 162 units
- Firm Location
- Sparks, MD
- Official Source
- View on FDA website ↗
Reason for Recall
Synapsys software versions 4.20, 4.30, 5.10, 5.20, or 5.30 and utilizing the in-line breakpoint feature, an error is occurring where BD Synapsys will incorrectly display breakpoints for organisms that do not have defined breakpoints in CLSI or EUCAST. This occurs when the identified organism is included in the same interpretive group as a species for which there is a specific breakpoint. May result in either a false susceptible or false resistant result. A false susceptible result can cause inadequate or incomplete antibiotic treatment due to the use of an ineffective antibiotic, and a false resistant result may limit access to a preferred antibiotic regimen with possible elongation of therapy
Distribution
Nationwide Foreign: Australia, New Zealand, Singapore, Hong Kong, Taiwan, Japan, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom, Russia, Saudi Arabia, South Africa, Canada, Mexico, China
Lot / Code Info
UDI-DI: 00382904441500 Software versions: 4.20, 4.30, 5.10, 5.20 and 5.30
Root Cause
Under Investigation by firm
Action Taken
BD issued Urgent Medical Device Correction letter on 12Sep2024. Letter states reason for recall, health risk and action to take: 1.Immediately identify if you have the affected software version noted in the affected product tableabove. Reference Attachment 2 for software version verification instructions. 2.Determine if the feature is active in your system by reviewing the system settings. Refer toAttachment 3 for System settings breakpoint feature instructions. 3.If the inline breakpoint feature is enabled, please disable the feature and keep disabled untilupgraded to Synapsys" software versions 5.31 or later. Refer to Attachment 3 for Systemsettings breakpoint feature instructions. 4.Ensure the contents of this notification are read and understood. 5.Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 6.Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the affected software versions, so that BD may acknowledge your receipt of this notification per FDA requirements. Actions taken by BD 1.BD has identified the root cause and is taking action to prevent recurrence of this product issue. 2.BD has resolved the issue in software versions 5.31 and later. If you require further assistance, please contact: BD Contact US Contact Information Areas of Support North American Regional Complaint Center Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Complaints when prompted Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com